收缩
收缩
| 货号： | 规格： | ||||||||||||||
| 品牌： | 热销产品 | 价格： | ￥ | ||||||||||||
| 产品分类： | 热销产品 | 研究领域： | |||||||||||||
| CAS编号： | 910463-68-2 | 分子量： | 4113.6 | ||||||||||||
| 分子式： | C187H291N45O59 | 别名： | |||||||||||||
| 储存条件： | Store at -20℃ | 运输条件： | ship with blue ice | ||||||||||||
| 货期： | 应用： | ||||||||||||||
| 说明书： | 备注： | ||||||||||||||
| 产品描述 | |||||||||||||||
|
维百奥生物现货销售司美格鲁肽标准品 | 910463-68-2 | 产品信息 品名：NebuPeptide™ Semaglutide (Peptide Reference) 司美格鲁肽 货号：NBS-233755 品牌：Nebulabio 规格：1mg；5mg；100mg；1g；Bulk | 产品属性
| 产品描述 NebuPeptide™ Semaglutide (Peptide Reference)(CAT#NBS-233755) is synthesized in accordance with the Semaglutide sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Semaglutide reference peptide ranging from milligrams to kilograms. | 产品背景 Semaglutide (NNC 0113-0217; NNC-0113-0217; Ozempic) is a novel and potent agonist of glucagon-like peptide-1 (GLP-1) receptor and belongs to the long-acting GLP-1 analogue. It is authorized for use in the management of type 2 diabetes. Liraglutide, an agonist of the glucagon-like peptide-1 (GLP-1) receptor, likewise demonstrated strong neuroprotective effects in animal models of Parkinson's disease. Furthermore, PD patients benefiting from the GLP-1 mimetic exendin-4 have demonstrated positive protective effects in a phase II clinical trial. |
|||||||||||||||
